WITHDRAWN: A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery.

Nanomedicine

Department of Biomedical Sciences, Center of Excellence for Infectious Diseases, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA.

Published: January 2012

AI Article Synopsis

Article Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nano.2012.01.002DOI Listing

Publication Analysis

Top Keywords

withdrawn novel
4
novel therapeutic
4
therapeutic system
4
system malignant
4
malignant glioma
4
glioma nanoformulation
4
nanoformulation pharmacokinetic
4
pharmacokinetic anticancer
4
anticancer properties
4
properties cell-nano-drug
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!